Pentixapharm Holding AG

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

68.17%

Shs. 5Y

—

Rev. 5Y

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company was founded in 2024 and is headquartered in Berlin, Germany.

Related entities

Subsidiaries

Pentixapharm AG

URL

https://www.pentixapharm.com/

IPO date

Oct 03, 2024

Employees

Domiciled in

Incorporated in

Headquarters & legal address

Robert-Rössle-Straße, 10
Berlin 13125
DE

Valuation

No data to show